Jiangsu Wecare Biotechnology

Manufacturer of probiotics and its derivatives

placeSuzhou, Jiangsu, China calendar_todayFounded 2013 language wecare-bio.com

Innovation

42 patent families — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 240 times.

YearFilings
20163
20178
20186
20193
202021
20213

Investor mix

7 investors on record; lead investors include Suzhou Guofa Venture Capital Holdings, China Merchants Capital, SDIC Chuanghe Fund Management, Suzhou Ventures Group.

Investor typeCountShare
Venture capital229%
Private equity457%
Other / undisclosed114%
Coming soon